Back to today’s briefing

Story perspectives

Georgie Maynard Fights Glioblastoma, Urges Research Investment

3/24/2025

34 7

Summary

Story summary

Georgie Maynard, facing an aggressive glioblastoma diagnosis since May 2023, bravely underwent an awake craniotomy. While her tumor remains stable, the harsh reality is a life expectancy of just 12-15 months. Passionately, she calls for greater investment in brain tumor research, highlighting that only £15m of a promised £40m has been utilized since 2018.

1 of 1

Story summary

Georgie Maynard, facing an aggressive glioblastoma diagnosis since May 2023, bravely underwent an awake craniotomy. While her tumor remains stable, the harsh reality is a life expectancy of just 12-15 months. Passionately, she calls for greater investment in brain tumor research, highlighting that only £15m of a promised £40m has been utilized since 2018.